APDN Schedules FY2’21 Financial Results Conference Call and Webcast for Thursday, May 13, 2021
May 7th, 2021
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
APDN Schedules FY’21 Q2 Financial Results Conference Call/Webcast
May 7th, 2021
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6th, 2021
Applied DNA Signs New Contract with U.S. Defense Logistics Agency
May 5th, 2021
APDN Secures Amendment to MSA and 4th Blanket Purchase Order
April 26th, 2021
APDN Provides Preliminary Estimated FQ2’21 Revenue Range and Business Update
April 21st, 2021
The Value of Data in Today’s Sustainability Challenges
April 19th, 2021
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily
April 8th, 2021